Table I.
5-year follow-up after treatment by endoscopic staging, stratifying results according to the clinical cytological grading.
| Improved | Not modified | Worsening | ||||
|---|---|---|---|---|---|---|
| Cases | Controls | Cases | Controls | Cases | Controls | |
| GCC 1-3 | 9/27 (33.3%) |
0/15 (0%) |
16/27 (59.2%) | 2/15 (13.3%) |
2/27 (7.4%) |
13/15 (86.6%) |
| GCC 4-6 | 6/83 (7.2%) |
0/32 (0%) |
31/83 (37.34%) | 8/32 (25%) |
46/83 (55%) |
24/32 (75%) |
| GCC ≥7 | 0/35 (0%) |
0/12 (0%) |
14/35 (40%) | 0/12 (0%) |
21/35 (60%) |
12/12 (100%) |
| Totale | 15/145* (10.3%) |
0 (0%) |
61/145* (42%) |
10/59 (16.9%) |
69/145* (47.5%) |
49/59 (83%) |
*
p < 0.05